Page last updated: 2024-10-28
hydralazine and Adenocarcinoma Of Kidney
hydralazine has been researched along with Adenocarcinoma Of Kidney in 2 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
"Renal cell carcinoma and hydralazine drug therapy has each been reported as rare associations with pauci-immune renal vasculitis." | 7.72 | P-ANCA positive renal vasculitis in association with renal cell carcinoma and prolonged hydralazine therapy. ( Jeffrey, RF; Leeds, J; Norris, JH, 2003) |
"Renal cell carcinoma and hydralazine drug therapy has each been reported as rare associations with pauci-immune renal vasculitis." | 3.72 | P-ANCA positive renal vasculitis in association with renal cell carcinoma and prolonged hydralazine therapy. ( Jeffrey, RF; Leeds, J; Norris, JH, 2003) |
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Norris, JH | 1 |
Leeds, J | 1 |
Jeffrey, RF | 1 |
Knowles, HJ | 1 |
Tian, YM | 1 |
Mole, DR | 1 |
Harris, AL | 1 |
Other Studies
2 other studies available for hydralazine and Adenocarcinoma Of Kidney
Article | Year |
---|---|
P-ANCA positive renal vasculitis in association with renal cell carcinoma and prolonged hydralazine therapy.
Topics: Antibodies, Antineutrophil Cytoplasmic; Antihypertensive Agents; Carcinoma, Renal Cell; Humans; Hydr | 2003 |
Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases.
Topics: Adrenomedullin; Angiogenesis Inducing Agents; Animals; Breast Neoplasms; Carcinoma; Carcinoma, Renal | 2004 |